We considered two possibilities: one is that occludin deficiency directly decreases claudin-5 and ZO-1, and the other is that occludin deficiency exacerbates tissue damage, including BBB destruction, after stroke, which secondarily leads to more severely reduced claudin-5 and ZO-1. The gene discussed is CLDN5; the disease is stroke disorder.